Concepedia
4
Publications
149
Citations
H-Index
2015
Active since
Affiliations
The University of Texas MD Anderson Cancer Center(Current)
Sun Yat-sen University
Actelion (Switzerland)
Sixth Affiliated Hospital of Sun Yat-sen University
Mark Seungwook Kim is an author at The University of Texas MD Anderson Cancer Center.
Publications per year
2015–2020
Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
Sun-Jin Kim, Ho Jeong Lee, Mark Seungwook Kim et al. · Clinical Cancer Research · 2015 · 60 citations · Full text
Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel
Ho Jeong Lee, Masaki Hanibuchi, Sun-Jin Kim et al. · Neuro-Oncology · 2016 · 56 citations · Full text
GnRH-R–Targeted Lytic Peptide Sensitizes <i>BRCA</i> Wild-type Ovarian Cancer to PARP Inhibition
Shaolin Ma, Sunila Pradeep, Alejandro Villar‐Prados et al. · Molecular Cancer Therapeutics · 2019 · 17 citations · Full text
Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer
Mark Seungwook Kim, Shaolin Ma, Anca Chelariu-Raicu et al. · Molecular Cancer Therapeutics · 2020 · 16 citations · Full text
Rows per page
1–4 of 4